- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Acute allergic reaction with anaphylaxis
- Meeting Date: March 2026
- Public Summary Document (PSD) March 2026 PBAC Meeting - (PDF)
- Public Summary Document (PSD) March 2026 PBAC Meeting - (DOCX)
Adrenaline (epinephrine) – March 2026
Nasal spray device 1 mg in 1 actuation, Nasal spray device 2 mg in 1 actuation,
Last updated
11 March 2026